Whole-Exome Sequencing Analysis of Alzheimer’s Disease in Non-APOE*4 Carriers
Year: 2020
Type: article
Study design: Observational Study
Abstract: The genetics of late-onset Alzheimer's disease (AD) is complex due to the heterogeneous nature of the disorder. APOE*4 is the strongest genetic risk factor for AD. Genome-wide association studies have identified more than 30 additional loci, each having relatively small effect size. Known AD loci explain only about 30% of the genetic variance, and thus much of the genetic variance remains unexplained. To identify some of the missing heritability of AD, we analyzed whole-exome sequencing (WES) data focusing on non-APOE*4 carriers from two WES datasets: 720 cases and controls from the University of Pittsburgh and 7,252 cases and controls from the Alzheimer's Disease Sequencing Project. Following separate WES analyses in each dataset, we performed meta-analysis for overlapping markers present in both datasets. Among the four variants reaching the exome-wide significance threshold, three were from known AD loci: APOE/rs7412 (odds ratio (OR) = 0.40; p = 5.46E-24), TOMM40/rs157581 (OR = 1.49; p = 4.04E-07), and TREM2/rs75932628 (OR = 4.00; p = 1.15E-07). The fourth significant variant, rs199533, was from a novel locus on chromosome 17 in the NSF gene (OR = 0.78; p = 2.88E-07). NSF was also significant in the gene-based analysis (p = 1.20E-05). In the GTEx data, NSF/rs199533 is a cis-eQTL for multiple genes in the brain and blood, including NSF that is highly expressed across all brain tissues, including regions that typically show amyloid-β accumulation. Further characterization of genes that are affected by NSF/rs199533 may help to shed light on the roles of these genes in AD etiology.
Source: Journal of Alzheimer s Disease
DOI: 10.3233/jad-200037
Institution: University of Pittsburgh
Language: English
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Keyword: late-onset Alzheimer's disease
Open Access status: green
Awards: G1052397333, G1135917780, G1220223050, G1243299691, Genetic Architecture of Alzheimer’s disease Proteinopathies, CORONARY HEART DISEASE AND STROKE, CORONARY HEART DISEASE &STROKE IN PEOPLE AGED 65-84, G1527150935, CORONARY HEART DISEASE AND STROKE, G1691174148, Mild Cognitive Impairment: a Prospective Community Study, G173303992, G1941623656, CHARGE: Identifying Risk & Protective SNV for AD in ADSP Case-control Sample, Large Scale Sequencing and Analysis of Genomes, G2194386449, CORONARY HEART DISEASE &STROKE IN PEOPLE AGED 65-84, G2391884931, Deep Resequencing of Candidate Gene Regions in Late-onset Alzheimer's Disease, CORONARY HEART DISEASE &STROKE IN THE ELDERLY, G278200998, G2818629771, A Platform for Large-Scale Genomic Discovery, G3045517347, Alzheimer's Disease Research Center, G3114902838, G3220743633, National Alzheimer's Coordinating Center, G3405256882, G3410686264, G3462919067, CHS research resources for the cardiovascular health of older adults, ADSP Follow-up in Multi-Ethnic Cohorts via Endophenotypes, Omics & Model Systems, G3839646794, CENTRAL BLOOD ANALYSIS LABORATORY FOR CHS, Predictors of Alheimers Disease in Mild Cognitive Impairment, Replication and Extension of ADSP Discoveries in African-Americans, The Human Genome Sequencing Center, G457330776, ARIC Neurocognitive Study (ARIC-NCS) Renewal UNC 4 of 5, Search for the Alzheimers Genes, G494123624, ARIC Neurocognitive Study (ARIC-NCS) Renewal 4 of 5, Temporal Trends, Novel Imaging and Molecular Characterization of Preclinical and Clinical Alzheimer's Disease in the Framingham Cohorts, G5164707915, Whole Genome Sequencing in Ethnically Diverse Cohorts for the ADSP Follow-Up Study (FUS), Alzheimer's Disease Genetics Consortium, G5479317095, Preclinical AD: Correlates of Amyloid, Tau PET and fcMRI in Framingham Gen 3 Young Adults, Dissecting genetic complexity of Alzheimer's disease and cognitive function, MRI, Cognitive, Genetic and Biomarker Precursors of AD & Dementia in Young Adults, G567847597, G581887176, CHARGE consortium: omics discovery for CVD and aging phenotypes, CHS Events Follow-up Study, Consortium for Alzheimers Sequence Analysis (CASA), Sequence-based Discovery of AD Risk & Protective Alleles, G6226795708, The Framingham Heart Study, G6548750934, CHS-Transition Phase, ARIC Neurocognitive Study (ARIC-NCS) Renewal 2 of 5, ARIC Neurocognitive Study (ARIC-NCS), Mechanisms of Small Vessel Related Brain Damage and Cognitive Impairment, G7176672723, Exceptional Survival: Trajectories to Functional Aging (CHS All Stars), The ARIC and Neurocognitive Longitudinal Study, Sequence-based Discovery of AD Risk & Protective Alleles, Genetic Architecture of Alzheimer's disease Proteinopathies, Modifier Genes that Influence Age at Onset or Protect Against Development of Alzheimer's Disease (AD), AD Gene Discovery: Exome Chip, New Endophenotypes & Functional Studies in CHARGE, COGNITIVE TESTS, APOE, BRAIN MRI AND RISKS OF DEMENTIA, Identification and characterization of AD risk networks using multi-dimensional "omics" data, Building on GWAS for NHLBI-disease: the CHARGE consortium, Genome Center for Alzheimer's Disease (GCAD), Mild Cognitive Impairment: A Prospective Community Study, Alzheimer Disease Research Center, THE NIA GENETICS OF ALZHEIMER'S DISEASE DATA STORAGE SITE, ARIC Neurocognitive Study (ARIC-NCS) Renewal 2023-2028, Precursors of Stroke Incidence and Prognosis, National Centralized Repository for Alzheimer's Disease and Related Dementias (NCRAD)
OpenAlex ID: W3040850355
